BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Staging
14 results:

  • 1. The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).
    Kolasińska-Ćwikła AD; Konsek SJ; Buscombe JR; Maciejkiewicz K; Cichocki A; Roszkowska-Purska K; Sawicki Ł; Tenderenda M; Cwikla JB
    Nucl Med Rev Cent East Eur; 2019; 22(1):1-7. PubMed ID: 30276787
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC.
    Artiko V; Afgan A; Petrović J; Radović B; Petrović N; Vlajković M; Šobić-Šaranović D; Obradović V
    Nucl Med Rev Cent East Eur; 2016; 19(2):99-103. PubMed ID: 27479786
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Biochemical and Pathological Correlates of Successful Semen Cryopreservation From Patients With Testicular Cancer: A Single Tertiary Center Experience.
    Pong YH; Kao MH; Lu YC; Lee IC; Hsieh JT; Tsai VF; Chang HC
    Urology; 2016 Feb; 88():76-80. PubMed ID: 26610675
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of PTEN and mTOR in pancreatic neuroendocrine tumors.
    Han X; Ji Y; Zhao J; Xu X; Lou W
    Tumour Biol; 2013 Oct; 34(5):2871-9. PubMed ID: 23686804
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The clinical value of scintigraphy of neuroendocrine tumors using (99m)Tc-HYNIC-TOC.
    Artiko V; Sobic-Saranovic D; Pavlovic S; Petrovic M; Zuvela M; Antic A; Matic S; Odalovic S; Petrovic N; Milovanovic A; Obradovic V
    J BUON; 2012; 17(3):537-42. PubMed ID: 23033296
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
    Gabriel M; Hausler F; Bale R; Moncayo R; Decristoforo C; Kovacs P; Virgolini I
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1440-51. PubMed ID: 16133384
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
    Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
    Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Fluorodeoxyglucose (FDO) positron emission tomography (PET) in testicular germ cell tumors in adults: preliminary French clinical evaluation, development of the technique and its clinical applications].
    Maszelin P; Lumbroso J; Theodore C; Foehrenbach H; Merlet P; Syrota A
    Prog Urol; 2000 Dec; 10(6):1190-9. PubMed ID: 11217558
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
    Macfarlane DJ; Sondak V; Johnson T; Wahl RL
    J Clin Oncol; 1998 May; 16(5):1770-6. PubMed ID: 9586890
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Role of computed tomography in the staging of patients with local-regional metastases of melanoma.
    Buzaid AC; Tinoco L; Ross MI; Legha SS; Benjamin RS
    J Clin Oncol; 1995 Aug; 13(8):2104-8. PubMed ID: 7636554
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
    Grem JL; Trump DL
    J Clin Oncol; 1986 Jan; 4(1):41-5. PubMed ID: 2416888
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Testicular neoplasms with massive tumor invasion. Consequences for diagnosis and therapy].
    Clemm C; Hartenstein R; Wilmanns W
    Fortschr Med; 1982 Oct; 100(39):1783-8. PubMed ID: 6891366
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Malignant ovarian tumors in childhood].
    Zucker JM
    Bull Cancer; 1982; 69(3):304-13. PubMed ID: 6181838
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.